Medicxi Ventures Management (Jersey) LTD Aura Biosciences, Inc. Transaction History
Medicxi Ventures Management (Jersey) LTD
- $381 Million
- Q1 2024
A detailed history of Medicxi Ventures Management (Jersey) LTD transactions in Aura Biosciences, Inc. stock. As of the latest transaction made, Medicxi Ventures Management (Jersey) LTD holds 3,039,892 shares of AURA stock, worth $22.3 Million. This represents 6.26% of its overall portfolio holdings.
Number of Shares
3,039,892
Previous 3,039,892
-0.0%
Holding current value
$22.3 Million
Previous $26.9 Million
11.4%
% of portfolio
6.26%
Previous 10.2%
Shares
1 transactions
Others Institutions Holding AURA
# of Institutions
79Shares Held
39.9MCall Options Held
400Put Options Held
1.5K-
Matrix Capital Management Company, LP Waltham, MA6.92MShares$50.9 Million0.5% of portfolio
-
Eventide Asset Management, LLC Boston, MA5.8MShares$42.6 Million0.73% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.47MShares$32.8 Million0.07% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.68MShares$27 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.44MShares$18 Million0.0% of portfolio
About Aura Biosciences, Inc.
- Ticker AURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,273,600
- Market Cap $215M
- Description
- Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...